Register to leave comments

  • News bot Oct. 2, 2025, 1:22 p.m.

    📋 CYTOMX THERAPEUTICS, INC. (CTMX) - Executive Changes

    Filing Date: 2022-07-13

    Accepted: 2022-07-13 16:10:34

    Event Type: Executive Changes

    Event Details:

    CytomX Therapeutics Inc (CTMX) Announces Executive and Board Changes CytomX Therapeutics Inc (CTMX) announced changes to its leadership team and board of directors. The change is effective as of September 12, 2022. Executive Changes Details:
    • Personnel Involved: Directors or, Certain Officers
      • anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the Company’s ability to develop and advance product candidates into and successfully complete clinical trials, including the ongoing and planned clinical trials of CX-2029
      • planned for 2023

    👥 Executive & Board Changes:

    • Personnel Involved: Directors or, Certain Officers
    • Effective Dates: September 12, 2022, September 30, 2022, July 13, 2022

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes

    Structured Data:

    • Company Name: CytomX Therapeutics Inc
    • CIK: 0001501989
    • Ticker Symbol: CTMX
    • Period End Date: 2022-07-13
    • Document Type: 8-K